4.1 Article

The Ca2+-dependent K+-channel KCa3.1 as a therapeutic target in cardiovascular disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

SKA-31, a novel activator of SKCa and IKCa channels, increases coronary flow in male and female rat hearts

Ramesh C. Mishra et al.

CARDIOVASCULAR RESEARCH (2013)

Review Pharmacology & Pharmacy

Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease

Ralf Kohler et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2010)

Review Physiology

Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses

Cor de Wit et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)

Review Physiology

Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice

Ralf Kohler et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)

Review Biochemistry & Molecular Biology

Signaling across Myoendothelial Gap JunctionsFact or fiction?

Cor de Wit et al.

CELL COMMUNICATION AND ADHESION (2008)

Article Medicine, Research & Experimental

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

Kazuyoshi Toyama et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Article Cardiac & Cardiovascular Systems

Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle

D. L. Tharp et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)